跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,748 条关于
“Hankang Capital”
全部
3,748
临床试验
674
药物
63
机构
124
资讯
2,887
去年
AusperBio Secures $73 Million to Advance Chronic Hepatitis B Therapy
去年
AusperBio Secures $50 Million Series B+ Funding to Advance Hepatitis B Functional Cure Candidate AHB-137
5个月前
Pinnacle Medicines Raises $89 Million Series B to Advance Oral Peptide Therapeutics into Clinical Trials
4个月前
Vivacta Bio Secures Over $50 Million in Series A Funding to Advance In Vivo CAR-T Therapy GT801
21天前
AusperBio Completes $120 Million Series C to Advance AHB-137 Toward Commercialization in Chronic Hepatitis B
去年
Sirius Therapeutics Secures $50 Million in Series B2 Funding to Advance siRNA Therapies for Cardiometabolic Diseases
去年
Faron Pharmaceuticals' Bexmarilimab Shows Promise in Myelodysplastic Syndrome Treatment
去年
IGM Biosciences Downgraded by BMO Capital Following Strategic Update
去年
Bain Capital Acquires Mitsubishi Tanabe Pharma in $3.3 Billion Deal
去年
Torrent Capital Secures $8.75M Financing to Expand Cryptocurrency Investment Portfolio
第 1 页,共 289 页
上一页
下一页